Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial
02. Mai 2024 06:00 ET
|
Smart Immune
Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial PARIS, France, May 2, 2024 – Smart Immune, a clinical-stage biotechnology company developing...